Lee J, Hong SW, Kim MJ, Moon SJ, Kwon H, Park SE, et al
It prevents bacterial growth inside the vial after opening, which is why a multi-dose bacteriostatic water vial can be used for up to 28 days while standard sterile water cannot
This cohort, known as the Taxonomy cohort 38 , comprised 156 stage II or stage III patients, 66 (35 male, 31 female) of whom went on to receive adjuvant 5FU-based chemotherapy (illustrated in Fig
Promising safety profile: Early trials report tolerability comparable to incretin-based agents, though higher doses are associated with GI side effects (nausea, diarrhea, vomiting, constipation) Clinical Advantage over Others (Clinical Trial Evidence) Phase 2 obesity studies: At 48 weeks, retatrutide delivered weight reductions up to 24%, far exceeding results reported for monotherapy GLP-1 agents
It is important to remember that in general, side effects are less common than many people think